Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -59.62% and Operating profit at -128.85% over the last 5 years
2
With a fall in Net Sales of -16.52%, the company declared Very Negative results in Sep 25
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,233 Million (Small Cap)
66.00
NA
0.00%
-0.28
1.10%
0.24
Revenue and Profits:
Net Sales:
96 Million
(Quarterly Results - Sep 2025)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.1%
0%
-10.1%
6 Months
-7.19%
0%
-7.19%
1 Year
12.11%
0%
12.11%
2 Years
-22.83%
0%
-22.83%
3 Years
-57.91%
0%
-57.91%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Assure Tech (Hangzhou) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-59.62%
EBIT Growth (5y)
-128.85%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.09
Tax Ratio
8.65%
Dividend Payout Ratio
79.30%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.62%
ROE (avg)
18.94%
Valuation key factors
Factor
Value
P/E Ratio
66
Industry P/E
Price to Book Value
0.94
EV to EBIT
-12.00
EV to EBITDA
57.09
EV to Capital Employed
0.65
EV to Sales
1.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.42%
ROE (Latest)
1.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
95.50
114.50
-16.59%
Operating Profit (PBDIT) excl Other Income
-21.80
-0.20
-10,800.00%
Interest
0.00
0.00
Exceptional Items
10.00
11.10
-9.91%
Consolidate Net Profit
5.10
25.00
-79.60%
Operating Profit Margin (Excl OI)
-228.00%
-134.90%
-9.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -16.59% vs -0.69% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -79.60% vs -26.90% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
537.20
494.80
8.57%
Operating Profit (PBDIT) excl Other Income
38.30
52.90
-27.60%
Interest
1.20
1.70
-29.41%
Exceptional Items
60.80
-49.60
222.58%
Consolidate Net Profit
192.20
141.00
36.31%
Operating Profit Margin (Excl OI)
-37.30%
-38.70%
0.14%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 8.57% vs -91.91% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 36.31% vs -95.37% in Dec 2023
About Assure Tech (Hangzhou) Co., Ltd. 
Assure Tech (Hangzhou) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






